Shopping Cart
Remove All
Your shopping cart is currently empty
Vasomera, a stable, long-acting vasoactive intestinal peptide (VIP) agonist, targets G-protein-coupled VPAC2 receptors and is employed in the study of cardiomyopathy associated with dystrophinopathies [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Vasomera, a stable, long-acting vasoactive intestinal peptide (VIP) agonist, targets G-protein-coupled VPAC2 receptors and is employed in the study of cardiomyopathy associated with dystrophinopathies [1]. |
| In vivo | Vasomera, administered intravenously at a dose of 7.5 μg/kg/min in a single infusion, enhances arterial elastance and ventriculo-arterial coupling, as well as indices of diastolic function (lusitropy), in animal models of chronic renoprival hypertension that replicate heart failure with preserved ejection fraction (HFpEF) [1]. |
| Cas No. | 1416067-68-9 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.